Base Year
Historical Year
Forecast Year
The North America colorectal cancer screening tests market size was valued at USD 5.94 billion in 2023. The market is further projected to grow at a CAGR of 5.6% between 2024 and 2032, reaching a value of USD 9.78 billion by 2032.
According to the North America colorectal cancer screening tests market report, a rising number of younger people are being diagnosed with colorectal cancer in North America. Factors contributing to an increase in colorectal cancer are an unhealthy diet, lack of physical activity, and a rise in smoking and alcohol consumption as well as genetics or family history. Symptoms of colorectal cancer include blood in stool, changes in bowel habits, and unexplained weight loss. Canadian provinces conduct routine colorectal cancer screening programs, which aids the market growth.
According to the North America colorectal cancer screening tests market analysis, the fecal immunochemical test (FIT) is an easy-to-use stool test that can also be done at home. It can help patients find colorectal cancer early, as well as precancerous conditions that if untreated might become colorectal cancer. In Canada, Ontario, and British Columbia recommend FIT screening every two years, while people living in Alberta are eligible for annual FIT screening. The U.S. Preventive Services Task Force recommends that adults aged between 45 to 75 be regularly screened for colorectal cancer. The colorectal cancer survival rate is rising in Canada and the United States supported by earlier detection of the cancer through routine examinations and screening and due to advances in treatments.
North America Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032 offers a detailed analysis of the market based on the following segments.
Market Breakup by Screening Tests
Market Breakup by End User
Market Breakup by Country
The key players in the colorectal cancer screening tests market in North America are producing highly efficient colorectal cancer screening tests.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Screening Tests |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2023, the colorectal cancer screening tests market reached an approximate value of USD 5.94 billion.
The market is expected to grow at a CAGR of 5.6% between 2024 and 2032.
The market is estimated to witness healthy growth in the forecast period of 2024-2032 to reach USD 9.78 billion by 2032.
A colonoscopy is one of the most sensitive tests available for colon cancer screening. The doctor views the patient’s entire colon and rectum and removes abnormal tissue, such as polyps during the exam.
Stool-based tests look at the stool for possible signs of colorectal cancer or polyps.
The major drivers of the market include rising occurrences of colorectal cancer in young patients, advancement in screening technology, and rising awareness of colorectal cancer.
Key trends aiding market expansion include rising emphasis on colorectal cancer screening, the availability of screening kits, and extensive research to enhance the quality and efficiency of colorectal cancer screening kits.
Major regions in the market are the United States of America and Canada.
The end user of colorectal cancer screening tests are hospitals, diagnostic centres/ laboratories, and others.
Key players in the market are Abbott Laboratories, 3T Medical Complete Systems, Epigenomics AG, Exact Sciences Corporation, Roche Diagnostics Corporation, Siemens AG, Sysmex Inostics, Inc., EKF Diagnostics Holdings Plc, Laboratory Corporation of America® Holdings., and LetsGetChecked Inc, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share